Reduced-Dose Radiation Therapy for HPV-Associated Oropharyngeal Carcinoma (NRG Oncology HN002)

Reducing radiation treatment dose could improve the quality of life (QOL) of patients with good-risk human papillomavirus–associated oropharyngeal squamous cell carcinoma (OPSCC). Whether reduced-dose radiation produces disease control and QOL equivalent to standard chemoradiation is not proven. PAT...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:J Clin Oncol
Glavni autori: Yom, Sue S., Torres-Saavedra, Pedro, Caudell, Jimmy J., Waldron, John N., Gillison, Maura L., Xia, Ping, Truong, Minh T., Kong, Christina, Jordan, Richard, Subramaniam, Rathan M., Yao, Min, Chung, Christine H., Geiger, Jessica L., Chan, Jason W., O'Sullivan, Brian, Blakaj, Dukagjin M., Mell, Loren K., Thorstad, Wade L., Jones, Christopher U., Banerjee, Robyn N., Lominska, Christopher, Le, Quynh-Thu
Format: Artigo
Jezik:Inglês
Izdano: Wolters Kluwer Health 2021
Teme:
ORIGINAL REPORTS
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8078254/
https://ncbi.nlm.nih.gov/pubmed/33507809
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.20.03128
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items